Clinical trials sponsored by Regina Elena Cancer Institute
11
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 2 2Not applicable 9
Conditions studied
Recruiting trials led by Regina Elena Cancer Institute
- Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
- Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab
- Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
- Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
- Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy
- Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery
- Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation
- Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
- Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.
- Versatile Ampification Single-Molecule Detection in Liquid Biopsy
- Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
Common questions
How many trials is Regina Elena Cancer Institute recruiting for?
Regina Elena Cancer Institute is the lead sponsor of 11 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.